Alspaugh J.A., Cavallo L.M., Perfect J.R., Heitman J.: RAS1 Regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. <em>Mol. Microbiol.</em> <bold>36</bold>, 352–365 (2000)
Altamirano S., Li Z., Fu M.S., Ding M., Fulton S.R., Yoder J.M., Tran V., Nielsen K. The Cyclin Cln1 Controls Polyploid Titan Cell Formation Following a Stress-Induced G2 Arrest in Cryptococcus. <em>mBio</em> <bold>12</bold>, e02509–21 (2021)
Antonelli G., Cutler S.: Evolution of the Koch postulates: towards a 21st-century understanding of microbial infection. <em>Clin Microbiol Infect.</em> <bold>22</bold>, 583–584 (2016)
Borman A.M., Simpson V.R., Palmer M.D., Linton C.J., Johnson E.M.: Adiaspiromycosis Due to Emmonsia crescens Is Widespread in Native British Mammals. <em>Mycopathologia</em> <bold>168</bold>, 153–163 (2009)
Boulware D.R., Meya D.B., Muzoora C., Rolfes M.A., Huppler Hullsiek K., Musubire A., Taseera K., Nabeta H.W., Schutz C., Williams D.A., Rajasingham R., Rhein J., Thienemann F., Lo M.W., Nielsen K., Bergemann T.L., Kambugu A., Manabe Y.C., Janoff E.N., Bohjanen P.R., Meintjes G.: Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis. <em>N. Engl. J. Med.</em> <bold>370</bold>, 2487–2498 (2014)
Casadevall A., Coelho C., Cordero R.J.B., Dragotakes Q., Jung E., Vij R., Wear M.P.: The Capsule of Cryptococcus neoformans. <em>Virulence</em> <bold>10</bold>, 822–831 (2019)
Casadevall A., Freij J.B., Hann-Soden C., Taylor J.: Continental Drift and Speciation of the Cryptococcus neoformans and Cryptococcus gattii Species Complexes. <em>mSphere</em> <bold>2</bold>, e00103–17 (2017)
Casadevall A., Pirofski L.A.: Host-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity. <em>Infect. Immun.</em> <bold>67</bold>, 3703–3713 (1999)
Charlier C., Chrétien F., Baudrimont M., Mordelet E., Lortholary O., Dromer F.: Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier. <em>Am. J. Pathol.</em> <bold>166</bold>, 421–432 (2005)
Chaturvedi A.K., Wormley F.L.: Methodology for Anti-Cryptococcal Vaccine Development BT – Vaccines for Invasive Fungal Infections: Methods and Protocols, Kalkum M., Semis M., (eds), Springer, New York 129–140 (2017)
Duin D., Casadevall A., Nosanchuk J.D.: Melanization of Cryptococcus Neoformans and Histoplasma Capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin. <em>Antimicrob. Agents Chemother.</em> <bold>46</bold>, 3394–3400 (2002)
Dyląg M., Colon-Reyes R.J., Kozubowski L.: Titan cell formation is unique to Cryptococcus species complex. <em>Virulence</em> <bold>11</bold>, 719–729 (2020)
Dyląg M., Colón-Reyes R.J., Loperena-Álvarez Y., Kozubowski L.: Establishing minimal conditions sufficient for the development of Titan-like cells in Cryptococcus neoformans/gattii species complex. <em>Pathogens</em> <bold>11</bold>, 768 (2022)
Esher S.K., Zaragoza Ó., Alspaugh J.A.: Cryptococcal Pathogenic Mechanisms: A Dangerous Trip from the Environment to the Brain. <em>Mem. Inst. Oswaldo Cruz</em> <bold>113</bold>, e180057 (2018)
Feldmesser M., Kress Y., Casadevall A.: Dynamic Changes in the Morphology of Cryptococcus neoformans during Murine Pulmonary Infection. <em>Microbiology</em> <bold>147</bold>, 2355–2365 (2001)
Franzot S.P., Salkin I.F., Casadevall A.: Cryptococcus neoformans var. grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates. <em>J. Clin. Microbiol.</em> <bold>37</bold>, 838–840 (1999)
Fu M.S., Coelho C., De Leon-Rodriguez C.M., Rossi D.C.P., Camacho E., Jung E.H., Kulkarni M., Casadevall A.: Cryptococcus neoformans Urease Affects the Outcome of Intracellular Pathogenesis by Modulating Phagolysosomal PH. <em>PLOS Pathog.</em> <bold>14</bold>, e1007144 (2018)
García-Barbazán I., Trevijano-Contador N., Rueda C., de Andrés B., Pérez-Tavárez R., Herrero-Fernández I., Gaspar M.L., Zaragoza O.: The Formation of Titan Cells in Cryptococcus neoformans Depends on the Mouse Strain and Correlates with Induction of Th2-Type Responses. <em>Cell. Microbiol.</em> <bold>18</bold>, 111–124 (2016)
Geddes J.M.H., Caza D., Croll N., Stoynov L.J., Foster J.W., Kronstad J.: Analysis of the Protein Kinase A-Regulated Proteome of Cryptococcus neoformans Identifies a Role for the Ubiquitin-Proteasome Pathway in Capsule Formation. <em>mBio</em> <bold>7</bold>, e01862–15 (2016)
Gerik K.J., Bhimireddy S.R., Ryerse J.S., Specht C.A., Lodge J.K.: PKC1 Is Essential for Protection against Both Oxidative and Nitrosative Stresses, Cell Integrity, and Normal Manifestation of Virulence Factors in the Pathogenic Fungus Cryptococcus neoformans. <em>Eukaryot. Cell</em> <bold>7</bold>, 1685–1698 (2008)
Gewiss M.E., Guilhem J., James C., Clemens S., Shun F.M., Frédérique M., Torsten K., Jochen B.: Cryptococcus neoformans Senses CO<sub>2</sub> through the Carbonic Anhydrase Can2 and the Adenylyl Cyclase Cac1. <em>Eukaryot. Cell</em> <bold>5</bold>, 103–111 (2006)
Giles S.S., Batinic-Haberle I., Perfect J.R., Cox G.M.: Cryptococcus neoformans Mitochondrial Superoxide Dismutase: An Essential Link between Antioxidant Function and High-Temperature Growth. <em>Eukaryot. Cell</em> <bold>4</bold>, 46–54 (2005)
Haag-Liautard C., Coffey N., Houle D., Lynch M., Charlesworth B., Keightley P.D.: Direct Estimation of the Mitochondrial DNA Mutation Rate in Drosophila Melanogaster. <em>PLOS Biol.</em> <bold>6</bold>, e204 (2008)
Hagen F., Khayhan K., Theelen B., Kolecka A., Polacheck I., Sionov E., Falk R., Parnmen S., Lumbsch H.T., Boekhout T.: Recognition of Seven Species in the Cryptococcus gattii/Cryptococcus neoformans Species Complex. <em>Fungal Genet. Biol.</em> <bold>78</bold>, 16–48 (2015)
Hawksworth D.L.: A New Dawn for the Naming of Fungi: Impacts of Decisions Made in Melbourne in July 2011 on the Future Publication and Regulation of Fungal Names. <em>IMA Fungus</em> <bold>2</bold>, 155–162 (2011)
Jain N., Guerrero A., Fries B.C.: Phenotypic Switching and Its Implications for the Pathogenesis of Cryptococcus neoformans. <em>FEMS Yeast Res.</em> <bold>6</bold>, 480–488 (2006)
Khajo A., Bryan R.A., Friedman M., Burger R.M., Levitsky Y., Casadevall A., Magliozzo R.S., Dadachova E.: Protection of Melanized Cryptococcus Neoformans from Lethal Dose Gamma Irradiation Involves Changes in Melanin’s Chemical Structure and Paramagnetism. <em>PLoS One</em> <bold>6</bold>, e25092 (2011)
Kraus P.R., Heitman J.: Coping with Stress: Calmodulin and Calcineurin in Model and Pathogenic Fungi. <em>Biochem. Biophys. Res. Commun.</em> <bold>311</bold>, 1151–1157 (2003)
Kwon-Chung K.J.: A New Species of Filobasidiella, the Sexual State of Cryptococcus neoformans B and C Serotypes. <em>Mycologia</em> <bold>68</bold>, 942–946 (1976)
Kwon-Chung K.J., Boekhout T., Fell J.W., Diaz M.: Proposal to Conserve the Name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). <em>Taxon</em> <bold>51</bold>, 804–806 (2002)
Kwon-Chung K.J., Perfect J.R., Levitz S.M.: A Chronological History of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an Invaluable Forum for Growth of the Cryptococcal Research Field and Clinical Practice. <em>Mycopathologia</em> <bold>173</bold>, 287–293 (2012)
Kwon-Chung K.J., Polacheck I., Bennett J.E. Improved Diagnostic Medium for Separation of Cryptococcus neoformans var. neoformans (Serotypes A and D) and Cryptococcus Neoformans Var. Gattii (Serotypes B and C). <em>J. Clin. Microbiol.</em> <bold>15</bold>, 535–537 (1982)
Kwon-Chung K.J., Polacheck I., Popkin T.J.: Melanin-Lacking Mutants of Cryptococcus Neoformans and Their Virulence for Mice. <em>J. Bacteriol.</em> <bold>150</bold>, 1414–1421 (1982)
Kussell E., Leibler S.: Phenotypic Diversity, Population Growth, and Information in Fluctuating Environments. <em>Science</em> <bold>309</bold>, 2075–2078 (2005)
Luberto C., Martinez-Mariño B., Taraskiewicz D., Bolaños B., Chitano P., Toffaletti D.L., Cox G.M., Perfect J.R., Hannun Y.A., Balish E., del Poeta M.: Identification of App1 as a Regulator of Phagocytosis and Virulence of Cryptococcus neoformans. <em>J. Clin. Invest.</em> <bold>112</bold>, 1080–1094 (2003)
Ma, H., Croudace J.E., Lammas D.A., May R.C.: Expulsion of Live Pathogenic Yeast by Macrophages. <em>Curr. Biol.</em> <bold>16</bold>, 2156–2160 (2006)
Ma H., Hagen F., Stekel D.J., Johnston S.A., Sionov E., Falk R., Polacheck I., Boekhout T., May R.C.: The Fatal Fungal Outbreak on Vancouver Island Is Characterized by Enhanced Intracellular Parasitism Driven by Mitochondrial Regulation. <em>Proc. Natl. Acad. Sci.</em> <bold>106</bold>, 12980–12985 (2009)
Meyer W., Castañeda A., Jackson S., Huynh M., Castañeda E.: Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates. <em>Emerg. Infect. Dis. J.</em> <bold>9</bold>, 189–195 (2003)
Momin M., Webb G.: The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans. <em>Int. J. Mol. Sci.</em> <bold>22</bold>, e6302 (2021)
Muzazu S.G.Y., Assefa D.G., Phiri C., Getinet T., Solomon S., Yismaw G., Manyazewal T.: Prevalence of Cryptococcal Meningitis among People Living with Human Immuno-Deficiency Virus and Predictors of Mortality in Adults on Induction Therapy in Africa: A Systematic Review and Meta-Analysis. <em>Frontiers in Medicine.</em> <bold>9</bold>, e989265 (2022)
Netski D., Kozel T.R.: Fc-Dependent and Fc-Independent Opsonization of Cryptococcus neoformans by Anticapsular Monoclonal Antibodies: Importance of Epitope Specificity. <em>Infect. Immun.</em> <bold>70</bold>, 2812–2819 (2002)
Ngamskulrungroj P., Price J., Sorrell T., Perfect J.R., Meyer W.: Cryptococcus gattii Virulence Composite: Candidate Genes Revealed by Microarray Analysis of High and Less Virulent Vancouver Island Outbreak Strains. <em>PLoS One</em> <bold>6</bold>, e16076 (2011)
Odom A., Muir S., Lim E., Toffaletti D.L., Perfect J., Heitman J.: Calcineurin Is Required for Virulence of Cryptococcus neoformans. <em>EMBO J.</em> <bold>16</bold>, 2576–2589 (1997)
O’Meara T.R., Norton D., Price M.S., Hay C., Clements M.F., Nichols C.B., Alspaugh J.A.: Interaction of Cryptococcus neoformans Rim101 and Protein Kinase A Regulates Capsule. <em>PLOS Pathog.</em> <bold>6</bold>, e1000776 (2010)
Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M.: Estimation of the Current Global Burden of Cryptococcal Meningitis among Persons Living with HIV/AIDS. <em>AIDS</em> <bold>23</bold>, 525–530 (2009)
Pasteur L.: Memoirs sur les corpuscles organises qui existent dans l’atmosphere. Examen de la doctrine des generations spontanees. <em>Ann. Sci. Nat.</em> <bold>16</bold>, 5–98 (1861)
Pasteur L.: Sur les maladies virulentes, et en particulier sur la maladie appelee vulgairement cholera des poules. <em>C.R. Acad. Sci.</em> <bold>90</bold>, 248–249 (1880)
Rajasingham R., Smith R.M., Park B.J., Jarvis J.N., Govender N.P., Chiller T.M., Denning D.W., Loyse A., Boulware D.R.: Global Burden of Disease of HIV-Associated Cryptococcal Meningitis: An Updated Analysis. <em>Lancet. Infect. Dis.</em> <bold>17</bold>, 873–881 (2017)
Reiko I., Takashi S.S., Takako S.: Laccase and Melanizationin Clinically Important Cryptococcus Species Other than Cryptococcus neoformans. <em>J. Clin. Microbiol.</em> <bold>40</bold>, 1214–1218 (2002)
Rittershaus P.C., Kechichian T.B., Allegood J.C., Merrill A.H., Hennig M., Luberto C., Del Poeta M.: Glucosylceramide Synthase Is an Essential Regulator of Pathogenicity of Cryptococcus neoformans. <em>J. Clin. Invest.</em> <bold>116</bold>, 1651–1659 (2006)
Rizzo J., Wong S.S., Gazi A.D., Moyrand F., Chaze T., Commere P.H., Novault S., Matondo M., Péhau-Arnaudet G., Reis F.C.G., Vos M., Alves L.R., May R.C., Nimrichter L., Rodrigues M.L., Aimanianda V., Janbon G.: Cryptococcus Extracellular Vesicles Properties and Their Use as Vaccine Platforms. <em>J. Extracell. Vesicles</em> <bold>10</bold>, e12129 (2021)
Rodrigues M.L., Travassos L.R., Miranda K.R., Franzen A.J., Rozental S., de Souza W., Alviano C.S., Barreto-Bergter E.: Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth. <em>Infect. Immun.</em> <bold>68</bold>, 7049–7060 (2000)
Saidykhan L., Correia J., Romanyuk A., Peacock A.F.A., Desanti G.E., Taylor-Smith L., Makarova M., Ballou E.R., May R.C.: An in Vitro Method for Inducing Titan Cells Reveals Novel Features of Yeast-to-Titan Switching in the Human Fungal Pathogen Cryptococcus gattii. <em>PLOS Pathog.</em> <bold>18</bold>, e1010321 (2022)
Sanfelice F.: Contributo Alla Morfologia e Biologia Dei Blastomiceti Che Si Sviluppano Nei Succhi Di Alcuni Frutti. <em>Ann Ig.</em> <bold>4</bold>, 463–495 (1894)
Seeliger H.P.R.: The Discovery of Achorion Schoenleinii: Facts and “Stories”: Die Entdeckung Des Achorion Schoenleinii Tatsachen Und „Geschichten”. <em>Mycoses</em> <bold>28</bold>, 161–182 (1985)
Slutsky B., Staebell M., Anderson J., Risen L., Pfaller M., Soll D.R.: ‘White-Opaque Transition’: A Second High-Frequency Switching System in Candida albicans. <em>J. Bacteriol.</em> <bold>169</bold>, 189–197 (1987)
Trevijano-Contador N., de Oliveira H.C., García-Rodas R., Rossi S.A., Llorente I., Zaballos Á., Janbon G., Ariño J., Zaragoza Ó.: Cryptococcus neoformans Can Form Titan-like Cells in Vitro in Response to Multiple Signals. <em>PLOS Pathog.</em> <bold>14</bold>, e1007007 (2018)
Van Dyke M.C.C., Teixeira M.M., Barker B.M.: Fantastic Yeasts and Where to Find Them: The Hidden Diversity of Dimorphic Fungal Pathogens. <em>Curr. Opin. Microbiol.</em> <bold>52</bold>, 55–63 (2019)
Varma A., Wu S., Guo N., Liao W., Lu G., Li A., Hu Y., Bulmer G., Kwon-Chung K.J.: Identification of a Novel Gene, URE2, That Functionally Complements a Urease-Negative Clinical Strain of Cryptococcus neoformans. <em>Microbiology</em> <bold>152</bold>, 3723–3731 (2006)
Vecchiarelli A., Pericolini E., Gabrielli E., Chow S.K., Bistoni F., Cenci E., Casadevall A.: Cryptococcus neoformans Galactoxylomannan Is a Potent Negative Immunomodulator, Inspiring New Approaches in Anti-Inflammatory Immunotherapy. <em>Immunotherapy</em> <bold>3</bold>, 997–1005 (2011)
Voelz K., Johnston S.A., Smith L.M., Hall R.A., Idnurm A., May R.C.: ‘Division of Labour’ in Response to Host Oxidative Burst Drives a Fatal Cryptococcus gattii Outbreak. <em>Nat. Commun.</em> <bold>5</bold>, 5194 (2014)
Vogel R.A. The Indirect Fluorescent Antibody Test for the Detection of Antibody in Human Cryptococcal Disease. <em>J. Infect. Dis.</em> <bold>116</bold>, 573–580 (1966)
Wills E.P., Himmelreich U., Mylonakis E., Rude T., Toffaletti D., Cox G.M., Miller J.L., Perfect J.R.: Characterization and Regulation of the Trehalose Synthesis Pathway and Its Importance in the Pathogenicity of Cryptococcus neoformans. <em>Infect. Immun.</em> <bold>74</bold>, 5877–5887 (2006)
Xie S., Sao R., Braun A., Bottone E.J.: Difference in Cryptococcus neoformans Cellular and Capsule Size in Sequential Pulmonary and Meningeal Infection: A Postmortem Study. <em>Diagn. Microbiol. Infect. Dis.</em> <bold>73</bold>, 49–52 (2012)
Zaragoza O., Casadevall A.: Monoclonal Antibodies Can Affect Complement Deposition on the Capsule of the Pathogenic Fungus Cryptococcus Neoformans by Both Classical Pathway Activation and Steric Hindrance. <em>Cell. Microbiol.</em> <bold>8</bold>, 1862–1876 (2006)
Zhou X., Ballou E. R.: The Cryptococcus Neoformans Titan Cell: From In Vivo Phenomenon to In Vitro Model. <em>Curr. Clin. Microbiol. Reports</em> <bold>5</bold>, 252–260 (2018)